These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9679389)

  • 1. New options for diagnosing and treating acromegaly.
    Barkan AL
    Cleve Clin J Med; 1998; 65(7):343, 347-9. PubMed ID: 9679389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH receptor antagonist: mechanism of action and clinical utility.
    Surya SK; Barkan AL
    Rev Endocr Metab Disord; 2005 Jan; 6(1):5-13. PubMed ID: 15711909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Place of cabergoline in acromegaly: a meta-analysis.
    Sandret L; Maison P; Chanson P
    J Clin Endocrinol Metab; 2011 May; 96(5):1327-35. PubMed ID: 21325455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist.
    Jørgensen JO; Feldt-Rasmussen U; Frystyk J; Chen JW; Kristensen LØ; Hagen C; Ørskov H
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5627-31. PubMed ID: 16046586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic management of acromegaly].
    Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
    Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University.
    Fukuda I; Hizuka N; Murakami Y; Itoh E; Yasumoto K; Sata A; Takano K
    Intern Med; 2001 Oct; 40(10):987-92. PubMed ID: 11688841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of dose escalation and surgical debulking in patients with acromegaly treated with somatostatin analogs in a Romanian tertiary care center.
    Gheorghiu ML; Găloiu S; Vintilă M; Purice M; Hortopan D; Dumitraşcu A; Coculescu M; Poiană C
    Hormones (Athens); 2016 Apr; 15(2):224-234. PubMed ID: 27376425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical assessment of disease control in acromegaly: reappraisal of the glucose suppression test in somatostatin analogue (SA) treated patients.
    Christiansen Arlien-Søborg M; Trolle C; Alvarson E; Bæk A; Dal J; Otto Lunde Jørgensen J
    Endocrine; 2017 Jun; 56(3):589-594. PubMed ID: 28260207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center.
    Bacigaluppi S; Gatto F; Anania P; Bragazzi NL; Rossi DC; Benvegnu G; Nazzari E; Spaziante R; Giusti M; Ferone D; Zona G
    Endocrine; 2016 Mar; 51(3):524-33. PubMed ID: 25982150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acromegaly; diagnosis and treatment].
    van der Lely AJ; de Herder WW; Hofland LJ; Lamberts SW
    Ned Tijdschr Geneeskd; 1996 Jul; 140(28):1436-40. PubMed ID: 8766766
    [No Abstract]   [Full Text] [Related]  

  • 11. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor 1 measurement in diagnosis and management of acromegaly.
    Peacey SR; Shalet SM
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):297-303. PubMed ID: 11471869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acromegaly and pregnancy.
    Caron P
    Ann Endocrinol (Paris); 2011 Sep; 72(4):282-286. PubMed ID: 21820101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
    Wass JA
    J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of treatment success in patients with acromegaly: the value of serum insulin-like growth factor binding protein-3 and serum leptin measurements in comparison to plasma insulin-like growth factor I determination.
    Páramo C; Fluiters E; de la Fuente J; Andrade A; García-Mayor RV
    Metabolism; 2001 Sep; 50(9):1117-21. PubMed ID: 11555849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly.
    Chanson P; Salenave S; Kamenicky P
    Handb Clin Neurol; 2014; 124():197-219. PubMed ID: 25248589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy with somatostatin analogues for acromegaly.
    Sassolas G
    Eur J Endocrinol; 1995 Dec; 133(6):675-7. PubMed ID: 8548050
    [No Abstract]   [Full Text] [Related]  

  • 18. Acromegaly.
    Nat Rev Dis Primers; 2019 Mar; 5(1):21. PubMed ID: 30899021
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy for the syndromes of GH excess.
    Arosio M; Cannavò S; Epaminonda P; Ronchi C; Chiodini I; Adda G
    J Endocrinol Invest; 2003; 26(10 Suppl):36-43. PubMed ID: 15497658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy.
    Ho KY; Weissberger AJ
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):75-83. PubMed ID: 8050134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.